This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Over the past decade, the reduction of maternal mortality in Latin America and the Caribbean has shown signs of a marked slowdown and in some cases a reversal, jeopardizing commitments made at the global and regional levels and by the Member States themselves, including those established in the Sust...ainable Development Goals.
more
This guideline document lays out the indicators for monitoring the 2016 Political Declaration on ending AIDS. The Global AIDS Monitoring (GAM) process has been often referenced as a benchmark for successful international accountability mechanisms.
Policy Brief
HIV testing services
December 2016
WHO/HIV/2016.21
This brochure contains the most relevant information on the Zero Maternal Deaths from Haemorrhage initiative, promoted by CLAP/PAHO.
Please read and download the latest updates at the website
http://www.who.int/hac/crises/ssd/epi/en/
HIV/TB Research Meeting; March 3, 2013
Extract from report of GACVS meeting of 3-4 December 2009, published in the WHO Weekly Epidemiological Record on 29 January 2010
FAST FACTS FROM THE 2013-14 ZAMBIA DEMOGRAPHIC AND HEALTH SURVEY
This country profile provides an overview of latest available data on a variety of HIV related topics in Mozambique as of 2016.
Key Malaria Indicators from the 2017 Rwanda Malaria Indicator Survey - The table in this key indicator report provides estimates of key indicators for the country as a whole and for each of the five provinces in Rwanda.
Key Findings (in booklet form) from the 2013 Rwanda Malaria Indicator Survey. The 2013 Rwanda Malaria Indicator Survey (RMIS) assessed malaria knowledge, prevention, and treatment practices. Over 4,700 households were interviewed.